Structural and biochemical insights into the molecular mechanism of TRPT1 for nucleic acid ADP-ribosylation
Nucleic Acids Research · 2023
DOI: 10.1093/nar/gkad525 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2023. Verfasst von Xiaoyun Yang und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Sciences, Hebei Innovation Center for Bioengineering and Biotechnology, Institute of Life Sciences and Green Development, Hebei Unive…. Hauptthemen laut MEDLINE: Phosphotransferases (Alcohol Group Acceptor), Saccharomyces cerevisiae Proteins. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Foundation of Hebei Educational Committee, Natural Science Foundation of Hebei Province.
Abstract (Originalsprache)
Nucleic acid ADP-ribosylation has been established as a novel modification found in a wide diversity of prokaryotic and eukaryotic organisms. tRNA 2′-phosphotransferase 1 (TRPT1/TPT1/KptA) possesses ADP-ribosyltransferase (ART) activity and is able to ADP-ribosylate nucleic acids. However, the underlying molecular mechanism remains elusive. Here, we determined crystal structures of TRPT1s in complex with NAD+ from Homo sapiens, Mus musculus and Saccharomyces cerevisiae. Our results revealed that the eukaryotic TRPT1s adopt common mechanisms for both NAD+ and nucleic acid substrate binding. The conserved SGR motif induces a significant conformational change in the donor loop upon NAD+ binding to facilitate the catalytic reaction of ART. Moreover, the nucleic acid-binding residue redundancy provides structural flexibility to accommodate different nucleic acid substrates. Mutational assays revealed that TRPT1s employ different catalytic and nucleic acid-binding residues to perform nucleic acid ADP-ribosylation and RNA 2′-phosphotransferase activities. Finally, cellular assays revealed that the mammalian TRPT1 is able to promote endocervical HeLa cell survival and proliferation. Together, our results provide structural and biochemical insights into the molecular mechanism of TRPT1 for nucleic acid ADP-ribosylation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- College of Life Sciences, Hebei Innovation Center for Bioengineering and Biotechnology, Institute of Life Sciences and Green Development, Hebei University, Baoding 071002, Hebei, China.
- School of Life Sciences, Southern University of Science and Technology, Shenzhen 518055, Guangdong, China.
- Shanghai Synchrotron Radiation Facility, Shanghai Advanced Research Institute, Chinese Academy of Sciences, Shanghai 201204, China.
ORCID-Profile: Xiaoyun Yang, Chen Wu, Xiuhua Liu
Förderung
- National Natural Science Foundation of China
- Foundation of Hebei Educational Committee
- Natural Science Foundation of Hebei Province
- Hebei Province Foundation for Returned Overseas Chinese Scholars
- Interdisciplinary Research Program of Natural Science of Hebei University
Zitieren
APA
Yang, X., Wang, J., Li, S., Li, X., Gong, J., Yan, Z., Zhou, H., Wu, C., & Liu, X. (2023). Structural and biochemical insights into the molecular mechanism of TRPT1 for nucleic acid ADP-ribosylation. Nucleic Acids Research. https://doi.org/10.1093/nar/gkad525
Vancouver
Yang X, Wang J, Li S, Li X, Gong J, Yan Z, et al. Structural and biochemical insights into the molecular mechanism of TRPT1 for nucleic acid ADP-ribosylation. Nucleic Acids Research. 2023. doi:10.1093/nar/gkad525
BibTeX
@article{Yang2023,
author = {Yang, Xiaoyun and Wang, Jiaxu and Li, Simin and Li, Xiaobing and Gong, Jingjing and Yan, Zhenzhen and Zhou, Huan and Wu, Chen and Liu, Xiuhua},
title = {Structural and biochemical insights into the molecular mechanism of TRPT1 for nucleic acid ADP-ribosylation},
journal = {Nucleic Acids Research},
year = {2023},
doi = {10.1093/nar/gkad525}
}
EUVIMED